Amending Regulations (EC) No 1272/2008, (EC) No 1223/2009 and (EU) 2019/1009 as regards simplification of certain requirements and procedures for chemical products

Tabled by Marie Toussaint

Added: Cosmetic products containing a substance classified as a CMR substance of category 1A, 1B, or 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 prohibited from use in cosmetic products and for which no derogation request was submitted in accordance with paragraph 2 or such substance is not compliant with a restriction may continue to be made available on the market until three months after the entry into force of the relevant amendments to the relevant Annexes to this Regulation. Cosmetic products containing a substance classified as a CMR substance of category 1A, 1B, or 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 prohibited from use in cosmetic products and for which a derogation request was submitted in accordance with paragraph 2, but not granted due to safety concerns by the SCCS or such substance not compliant with a restriction may continue to be made available on the market until three months after the entry into force of the relevant amendments to the relevant Annexes to this Regulation. Cosmetic products containing a substance classified as a CMR substance of category … use in cosmetic products or such substance not compliant with a restriction Added: and for which a derogation request was submitted in accordance with paragraph 2 of this Article, but not granted due to the availability of a suitable alternative, may continue to Removed: be placed on the market for 12 months and be made available on the market for 24 months after the entry into force of the relevant amendments to the relevant Annexes to this Removed: Regulation.’ Added: Regulation and where an updated cosmetic product safety report (CPSR) remains available, where needed.' (Amendment further away from the COM proposal as compared to AM 61 by deleting any delays for “placing on the market”, and by reducing the delays for making available on the market in the first two cases to three months as compared to fifteen or twelve months, outweighing not changing the delay of 24 months for the third case)

Wording as published by the EP, in English. PE783.026